NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$19.51
0.60 (3.17%)
▲
5d:
-7.27%
30d:
-12.67%
90d:
+18.53%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 27, 2026
0d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NRC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.30
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.65
23.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $19.51, which is considered oversold relative to its 30-day fair value range of $20.33 to $22.42. The stock's valuation (Forward PE: 18.6) is in line with its historical norms (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $17.88, while resistance sits at $23.68. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.00 (+33.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $17.88, while resistance sits at $23.68. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.00 (+33.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.33 -
$22.42
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 33.3% below Wall St target ($26.00)
- CAUTION: Recommendation downgraded due to -7.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$20.33 -
$22.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.88
Resistance Level
$23.68
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.58
Wall Street Target
$26.00
(+33.3%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-44.0%
Profit Margin
4.2%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
18.6 vs 20.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$18.96
(-3%)
2-Year Target
$18.43
(-6%)
3-Year Target
$17.92
(-8%)
3-Yr Target (if PE normalizes)
(PE: 19→20)
$19.48
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 218.2%)
$73.46
(+277%)
Base:
(SPY PE: 18.6, Growth: 218.2%)
$65.85
(+238%)
Bear:
(PE: 15.8, Growth: 218.2%)
$55.97
(+187%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.13
Bull Case
$23.56
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$19.51
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$14.93
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.6 to 20.2
Stabilization Target:
$21.21
(+8.7%)
PE Expansion Potential:
+8.7%
Share & Embed Analysis
Last updated: August 03, 2026 2:36 AM ET
Data refreshes hourly during market hours. Next update: 3:36 AM
Data refreshes hourly during market hours. Next update: 3:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
